Press Release | NeoGenomics Laboratories

August 16, 2022

NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 9, 2022

NeoGenomics Reports Revenue of $125 Million in the Second Quarter

July 21, 2022

NeoGenomics Announces Chief Executive Officer Appointment

July 15, 2022

NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022

June 21, 2022

NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer

June 3, 2022

NeoGenomics Receives CAP Certification in their Suzhou China Pharma Services Laboratory

June 3, 2022

NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences

May 16, 2022

NeoGenomics Appoints Lynn Tetrault Interim CEO

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients